跳至主要内容
临床试验/DRKS00022201
DRKS00022201招募中不适用

Associations of intestinal microbiota signatures with the efficacy and toxicity of chemotherapy in patients with advanced pancreatic cancer - PaCTx

German Cancer Research Center (DKFZ)0 个研究点目标入组 200 人开始时间: 2020年6月18日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Patients with locally advanced or metastatic PDAC or recurrence after primary PDAC resection who receive palliative chemotherapy based on medical indication.
  • - Persons who have understood the informed consent and signed the written consent form.

排除标准

  • - Refusal by the patient
  • - Age < 18 years
  • - Lack of ability to consent
  • - Pancreas resection with (neo)adjuvant chemotherapy
  • - Previous treatment of other malignant cancers

研究者

发起方
German Cancer Research Center (DKFZ)

相似试验